These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 18312313

  • 1. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
    Kaplan RC, McGinn AP, Pollak MN, Kuller L, Strickler HD, Rohan TE, Xue X, Kritchevsky SB, Newman AB, Psaty BM.
    J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
    [Abstract] [Full Text] [Related]

  • 2. Body mass index, free insulin-like growth factor I, and physical function among older adults: results from the ilSIRENTE study.
    Onder G, Liperoti R, Russo A, Soldato M, Capoluongo E, Volpato S, Cesari M, Ameglio F, Bernabei R, Landi F.
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E829-34. PubMed ID: 16684849
    [Abstract] [Full Text] [Related]

  • 3. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [Abstract] [Full Text] [Related]

  • 4. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
    Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, Hopper JL, Boyle P, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [Abstract] [Full Text] [Related]

  • 6. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
    Axelsson J, Qureshi AR, Divino-Filho JC, Bárány P, Heimbürger O, Lindholm B, Stenvinkel P.
    Eur J Clin Nutr; 2006 Jun; 60(6):718-26. PubMed ID: 16391585
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
    Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, Koenig KL, Dossus L, Riboli E, Stattin P, Lukanova A, Toniolo P.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
    [Abstract] [Full Text] [Related]

  • 8. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
    Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F.
    Clin Cancer Res; 2003 Oct 15; 9(13):4722-9. PubMed ID: 14581342
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun 15; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

  • 10. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
    Ahmed RL, Thomas W, Schmitz KH.
    Cancer Epidemiol Biomarkers Prev; 2007 Mar 15; 16(3):593-7. PubMed ID: 17372257
    [Abstract] [Full Text] [Related]

  • 11. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL, Elofsson S, Brismar K.
    Clin Endocrinol (Oxf); 2005 Jul 15; 63(1):94-102. PubMed ID: 15963068
    [Abstract] [Full Text] [Related]

  • 12. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.
    Breast Cancer Res Treat; 2004 Nov 15; 88(1):63-73. PubMed ID: 15538047
    [Abstract] [Full Text] [Related]

  • 13. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 15; 11(11):1413-8. PubMed ID: 12433720
    [Abstract] [Full Text] [Related]

  • 14. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS.
    Cancer; 2005 Jan 01; 103(1):76-84. PubMed ID: 15540247
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Rosen CJ.
    Gastroenterology; 2005 Aug 01; 129(2):464-75. PubMed ID: 16083703
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV, Potischman N, Madigan MP, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR, Fillmore CM, Sherman ME, Brinton LA.
    Cancer Epidemiol Biomarkers Prev; 2004 Apr 01; 13(4):607-12. PubMed ID: 15066926
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly.
    Denti L, Annoni V, Cattadori E, Salvagnini MA, Visioli S, Merli MF, Corradi F, Ceresini G, Valenti G, Hoffman AR, Ceda GP.
    Am J Med; 2004 Sep 01; 117(5):312-7. PubMed ID: 15336580
    [Abstract] [Full Text] [Related]

  • 18. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
    Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2000 Apr 01; 9(4):345-9. PubMed ID: 10794477
    [Abstract] [Full Text] [Related]

  • 19. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.
    Kaplan RC, McGinn AP, Pollak MN, Kuller LH, Strickler HD, Rohan TE, Cappola AR, Xue X, Psaty BM.
    J Clin Endocrinol Metab; 2007 Apr 01; 92(4):1319-25. PubMed ID: 17264182
    [Abstract] [Full Text] [Related]

  • 20. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
    Harris TG, Strickler HD, Yu H, Pollak MN, Monrad ES, Travin MI, Xue X, Rohan TE, Kaplan RC.
    Growth Horm IGF Res; 2006 Apr 01; 16(2):86-92. PubMed ID: 16530441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.